Carbohydrate restricted diet in conjunction with metformin and liraglutide is an effective treatment in patients with deteriorated type 2 diabetes mellitus: Proof-of-concept study

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Müller, Jürgen E ^a   Sträter Müller, Dagmar ^a   Marks, Hans Joachim ^b   Gläsner, Michael ^c   Kneppe, Philipp ^c   Clemens Harmening, Beate ^d   Menker, Harald ^c  

^a Internistische Praxis   (Germany)

^b Internistische Praxis   (Germany)

^c Internistische Praxis   (Germany)

^d Internistische Praxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLIMEPIRIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIRAGLUTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOW CARBOHYDRATE DIET; MALE; METABOLIC REGULATION; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84857064016     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-92     Document Type: Article

References (21)

1. Diabetes in Asia. Ramachandran A, Ma RCW, Snehalatha C, Lancet 2010 375 9712 408 418 10.1016/S0140-6736(09)60937-5 19875164
2. Nutrition Recommendations and Interventions for Diabetes. Association AD, Diabetes Care 2008 31 Supplement 1 61 S78 http://care.diabetesjournals.org/ content/31/Supplement-1/S61.short 18165339
3. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Howard BV, Horn LV, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SAA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM, JAMA 2006 295 6 655 666 10.1001/jama.295.6.655 16467234 (Pubitemid 43209067)
4. OBESITY: ITS PATHOGENESIS, ETIOLOGY AND TREATMENT. BAUER J, Arch Intern Med 1941 67 5 968 994 10.1001/archinte.1941.00200050076006
5. A Reorientation on Obesity. Pennington AW, New England Journal of Medicine 1953 248 23 959 964 10.1056/NEJM195306042482301 13046654
6. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC, JAMA 2007 297 9 969 977 10.1001/jama.297.9.969 17341711 (Pubitemid 46376751)
7. Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS, JAMA 2007 297 19 2092 2102 10.1001/jama.297.19.2092 17507345 (Pubitemid 46798167)
8. Serum triglycerides in coronary artery disease. ALBRINK MJ, MAN EB, AMA Arch Intern Med 1959 103 4 8 10.1001/archinte.1959.00270010010002 13605296
9. Glycaemic index as a determinant of serum HDL-cholesterol concentration. Frost G, Leeds AA, Dore CJ, Madeiros S, Brading S, Dornhorst A, Lancet 1999 353 9158 1045 1048 10.1016/S0140-6736(98)07164-5 10199351 (Pubitemid 29149912)
10. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Forsythe CE, Phinney SD, Feinman RD, Volk BM, Freidenreich D, Quann E, Ballard K, Puglisi MJ, Maresh CM, Kraemer WJ, Bibus DM, Fernandez ML, Volek JS, Lipids 2010 45 10 947 962 10.1007/s11745-010-3467-3 20820932
11. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, Gleed A, Jacobs DB, Larson G, Lustig RH, Manninen AH, McFarlane SI, Morrison K, Nielsen JV, Ravnskov U, Roth KS, Silvestre R, Sowers JR, Sundberg R, Volek JS, Westman EC, Wood RJ, Wortman J, Vernon MC, Nutr Metab (Lond) 2008 5 9 10.1186/1743-7075-5-9 (Pubitemid 351641966)
12. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Westman EC, Yancy WS, Mavropoulos JC, Marquart M, McDuffie JR, Nutr Metab (Lond) 2008 5 36 10.1186/1743-7075-5-36
13. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, Stein RI, Mohammed BS, Miller B, Rader DJ, Zemel B, Wadden TA, Tenhave T, Newcomb CW, Klein S, Ann Intern Med 2010 153 3 147 157 20679559
14. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, Zdravkovic M, Ravn GM, Simo R, Diabetologia 2009 52 10 2046 55 10.1007/s00125-009-1472-y 19688338
15. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Astrup A, Rössner S, Gaal LV, Rissanen A, Niskanen L, Hakim MA, Madsen J, Rasmussen MF, Lean MEJ, Group NNS, Lancet 2009 374 9701 1606 1616 10.1016/S0140-6736(09)61375-1 19853906
16. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997 277 11 925 926 9062334
17. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine 1993 329 14 977 986 http://www.nejm.org/doi/ full/10.1056/NEJM199309303291401 8366922 (Pubitemid 23307905)
18. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 9131 837 853 9742976
19. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes. New England Journal of Medicine 2011 364 9 818 828 http://www.nejm.org/doi/full/10.1056/NEJMoa1006524 21366473
20. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, Association AD, for Study of Diabetes EA, Diabetes Care 2009 32 193 203 10.2337/dc08-9025 18945920
21. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Gannon MC, Nuttall FQ, Nutr Metab (Lond) 2006 3 16 http://dx.doi.org/10.1186/1743-7075-3-16 10.1186/1743-7075-3-16 (Pubitemid 43872609)